Bahl & Gaynor Inc
Source: SEC Form 13F · as of Mar 2026Bahl & Gaynor Inc holds 20 biotech & pharma companies tracked by BioSniper, totaling $2.47B in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$2.47B
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 2,721,183 | $665.2M |
| LLYELI LILLY & Co | 666,129 | $612.7M |
| ABBVAbbVie Inc. | 2,738,634 | $595.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 852,428 | $230.7M |
| PMPhilip Morris International Inc | 601,173 | $99.4M |
| MRKMerck & Co., Inc. | 750,494 | $90.3M |
| ABTABBOTT LABORATORIES | 766,894 | $78.7M |
| AMGNAMGEN INC | 195,866 | $68.9M |
| NVSNovartis AG | 85,688 | $13.1M |
| DGXQuest Diagnostics Incorporated | 17,141 | $3.4M |
| BMYBRISTOL MYERS SQUIBB CO | 30,222 | $1.8M |
| CAHCardinal Health Inc. | 6,149 | $1.3M |
| ZTSZoetis Inc. | 10,163 | $1.2M |
| CORCencora Inc. | 2,514 | $790K |
| MCKMcKesson Corporation | 687 | $595K |
| PFEPFIZER INC | 20,743 | $582K |
| ZBHZimmer Biomet Holdings Inc. | 5,995 | $542K |
| WSTWest Pharmaceutical Services Inc. | 2,125 | $533K |
| GILDGILEAD SCIENCES, INC. | 2,122 | $296K |
| PRGOPERRIGO Co plc | 16,869 | $181K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.